Remove Patents Remove Pricing Remove San Diego Remove Technical Review
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

All those years of hard work to reach the promised land, then just as a drug owner is ready to spike it home and take a victory lap, the FDA’s hands rise over the net… OK, it’s not a perfect analogy, but it’s better than comparing the patent fight over the gene editing system CRISPR-Cas9 to table tennis. (Be

article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. Will he take a softer stance on drug prices? But her near doubling of Trump (62 to 33 percent) didn’t translate into support for drug price controls. Patent and Trademark Office. Now, the U.S. CRISPR DEVELOPMENTS.

Patents 87
article thumbnail

Interview with Dipanshu Sharma, Kadonk

socalTECH

This morning's interview is with San Diego-based Kadonk (www.kadonk.com), a startup which is creating project management tools that work with Microsoft Project. Often times, in the world of cell phones and high tech software, you don't know the challenges throughout the process of creating a product.

Startup 100